[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-insider-selling-abrdn-life-sci3301963feb-c93c-7589-86ee-742ead3a0f81":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23},"insider-selling-abrdn-life-sci3301963feb-c93c-7589-86ee-742ead3a0f81","1744827901000","Insider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 30,156 Shares of Stock","Abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) major shareholder Saba Capital Management, L.P. sold 30,156 shares of the business's stock in a transaction on Thursday, April 10th. The stock was sold at an average price of $11.14, for a total transaction of $335,937.84. Following the sale, the insider now directly owns 3,094,316 shares in the company, valued at approximately $34,470,680.24. The trade was a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.","https://www.marketbeat.com/instant-alerts/insider-selling-abrdn-life-sciences-investors-nysehql-major-shareholder-sells-30156-shares-of-stock-2025-04-14/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","5"]